Proteins are usually deciphered by translation of the coding genome; however, their amino acid residues are seldom determined directly across the proteome.
• Exon sequencing confirmed 40 of 98 ncAAs that matched with amino acid substitutions.
• Many ncAAs are linked with disease and have potential for diagnosis and targeting.
eTOC Blurb
We describe a systematic identification of all possible protein residues that were not encoded by their genomic sequences. A total of 571 high-confidence most novel noncoded amino acids were identified in human sperm proteome, corresponding to over 108,000 ncAA-containing protein sites. For validation, 40 out of 98 ncAAs that matched to amino acid substitutions were confirmed by exon sequencing. These ncAAs are discriminative between individuals and expand our understanding of amino acid polymorphisms in human proteomes and diseases.
INTRODUCTION
Proteins are polyamides that are encoded by their corresponding genes and built from 20 different types of amino acid. Protein residues are often subjected to post-translational modifications (PTMs), which are involved in regulation of protein folding, stability and activity, and ultimately their function (Beltrao et al., 2012; Mathias et al., 2015) . However, protein sequences are usually deciphered by translation of the coding genomic sequences and the actual protein residues are seldom determined directly across the proteome (Chick et al., 2015) . Thus, the actual structures of residues in proteins are assumed to be more complicated than thought. This is partially because protein sequencing technologies are usually dependent on proteins translated from their encoding genes (Mann and Wilm, 1994; Perkins et al., 1999) . The leading Shotgun proteomics technology, for instance, begins with enzymatic digestion of proteins, followed by mass determination of the digested peptides (precursors or MS), and collision-induced fragmentation of the peptides (products or MS/MS) using liquid chromatography-tandem mass spectrometry (LC-MS/MS). Peptide sequences are determined by matching the obtained MS and MS/MS spectra with the theoretical mases of translated or coding protein peptides using sophisticated search algorithms such as MASCOT (Smith and Frank, 2016) , SEQUEST (Lundgren et al., 2009) , and more recently, Byonic (Bern et al., 2012) . In matching algorithms, only the standard 20 amino acids and known modifications are considered, and undefined or noncoded protein residues that do not match these standards are usually neglected. Surprisingly, nearly half of high-quality MS/MS spectra do not match peptides in the available protein databases (Chick et al., 2015) . Even when considering known modifications, many spectra still do not match the coding proteins due to undefined noncoded protein residues.
To resolve unmatched peptide spectra, the existence of one or more undefined noncoded residues in peptides is often assumed. In early approaches, partial peptide sequences were derived from unmatched spectra and used as tags to search theoretically translated protein databases, thereby identifying unexpected PTMs and amino acid substitutions (Mann and Wilm, 1994; Tabb et al., 2003) . In iterative approaches, partially matched or de novogenerated mass tags are used to test mass iterations for multiple unexpected modifications (Bern et al., 2007; Kim et al., 2009) . Alternatively, unrestrictive search algorithms can identify noncoded residues without knowing whether or not they exist in nature (Tsur et al., 2005) . The mass-tolerant approach was originally used to detect known modifications by allowing for mass differences between a precursor and its fragment (Creasy and Cottrell, 2002) . This approach was recently improved by allowing a wide mass tolerance for precursors to match peptide sequences containing a wide range of delta masses or undefined modifications (Chick et al., 2015) . Although the high rate of false positives is still a major problem of these approaches, along with variable sensitivity and lengthy experiments, it is clear that unmatched peptide spectra are largely due to yet undefined noncoded protein residues. Since undefined noncoded amino acids indicate novel amino acid side-chains and structures, they are assumed to be important for protein function under both physiological and pathological conditions Sperm are highly differentiated cells in which many genes are transcriptionally and translationally silent. This study explored noncoded protein residues in human spermatozoa, with an emphasis on comparing healthy individuals and patients with oligoasthenospermia. Taking advantage of the high accuracy and fast data acquisition of mass spectrometry, a modified Shotgun proteomics method was used to measure all possible mass differences or delta masses between coding amino acids and actual protein residues in sperm proteins from 48 people. Over a million nonzero delta masses were obtained out of ~7 million peptides or 10,591 non-redundant proteins detected with high confidence. To account for the false positive rate, nonzero delta masses were clustered by a multi-variable model and further fitted by Gaussian regression to archive statistically clustered delta masses for calculation of high-confidence ncAAs and ncAA-containing protein sites. Our study revealed a large number of unreported ncAAs with undefined side-chain structures in human spermatozoa that are polymorphous in healthy populations and discriminative in patients with oligoasthenospermia.
RESULTS

Widespread and highly clustered delta masses in human sperm proteome
In this study, delta masses refer to mass differences between genetically encoded amino acids and the actual protein residues at the corresponding peptide position. The existence of "nonzero" delta masses indicate the presence of potential noncoded protein residues or noncoded amino acids, termed ncAAs. Positive and negative delta masses indicate mass gain and loss, respectively. A modified Shotgun proteomics approached was used to determine delta masses for spermatozoa proteins from 24 healthy individuals and 24 patients with oligoasthenospermia. The total proteins were separated into 510 fractions based on molecular weights by SDS-PAGE and in-gel trypsin digestion. Peptides (precursors, MS) and their breakdown fragments (products, MS/MS) were repeatedly determined 38 times by liquid chromatography-tandem mass spectrometry (LC-MS/MS) to maximise the number of high-quality peptide spectrum data. By allowing noncoded protein residues in peptides, the acquired MS and MS/MS data were matched against human protein databases using the multi-blind spectral alignment algorithm MODa (Na et al., 2012) , wide-tolerance SEQUEST (Chick et al., 2015) , and Byonic (Bern et al., 2007) . All three algorithms detected a large number of peptides with nonzero delta mass ( Fig. 1a) . For Byonic, 1,197,754 nonzero delta masses were detected ( Supplemental Table 1 ) out of 7,860,173 highconfidence peptides, indicating that approximately 15% of the peptides potentially included at least one ncAA in their sequence. All peptides were grouped into 10,591 non-redundant proteins (at least two peptides were required to identify a protein) with an average of 26.75% sequence coverage ( Fig. 1b) , representing the highest number and coverage of proteins identified from human spermatozoa to date.
Most nonzero delta masses were between -129 to 500 Da, and the occurrence of delta masses with smaller gains and losses increased exponentially ( Fig. 1c) . It should be noted that a delta mass of -129 Da is the theoretical maximum mass loss due to amino acid substitution, equivalent to the replacement of Tryptophan with Glycine. Thus, we reasoned that the mechanism underlying the mass loss of the ncAAs was largely due to amino acid substitutions, assumedly by single nucleotide polymorphisms (SNPs) at the DNA level or other not yet defined mechanisms. On the contrary, most of mass gains were undefined delta masses smaller than 500 Da that did not match amino acid substitutions or previously reported PTMs.
To characterise these delta masses, their frequencies were plotted against delta masses rounded to four decimal places. Indeed, delta masses were highly clustered ( Fig. 1d) , and some accurately matched previously reported protein modifications or amino acid substitutions. Besides that matching oxidation, the most abundant peak was 0.9846 Da, which matches hydrolytic deamination (0.9840 Da, error = 0.0006, n = 147,041). A well-documented peak was 79.9669
Da, which matches a phosphorylation modification (79.9663 Da, error = 0.0006, n = 12,758). In general, these delta masses with previously reported PTMs and amino acid substitutions, such as phosphorylation, acetylation, methylation, and ubiquitylation, were usually identified with high accuracy and high occurrence frequency. However, most of the clustered delta masses, especially those with sharp peaks and high abundance, were unknown and considered as undefined PTMs, amino acid substitutions, or generally ncAAs.
Multivariate Gaussian clustering and machine learning determination of
high-confidence ncAAs Based on clustering, these delta masses corresponded to molecular differences of some known and mostly unknown ncAAs. The widths of clustered peaks were typically within the lower ppm range and hence compatible with the accuracy of the Orbitrap mass spectrometer.
Given that errors were random, clusters with unknown delta masses were assumed to reflect novel protein modifications, substitutions or generally ncAAs.
To quantitatively identify all ncAAs, delta masses were divided into subgroups with 1 Da intervals and analysed by multivariate clustering using Gaussian mixture components (Fraley et al., 2012) . Gaussian regression was followed to each cluster to determine the peak value (expected cluster), the standard deviation (SD), and the Goodness-of-Fit (R 2 ), which resulted in 617 qualified delta masses (Supplemental Table 2 ). These delta mass clusters were further compared with the delta masses previously reported PTMs and substitutions, including those found in the UniMod (Creasy and Cottrell, 2004) , RESID (Garavelli, 2004) , ExPASy (Gasteiger et al., 2003) and ABRF (Arnott et al., 2003) databases (Supplemental Table 3 ). As a result, 192 clusters closely matched the previously reported delta masses, and 232 did not. In total, 424 clustered delta masses were confidently assigned ( Supplemental Table S4 ). Among the unmatched clusters, 136 were qualified by R 2 >0.2, and 96 reflected selective occurrence over a given amino acid (frequency >50%). It should be noted that the number of matched clusters did not significantly vary with R 2 value ( Fig. 2a) ; however，the number of unmatched clusters dramatically increased when R 2 <0.2, representing a turning point for unreliable clusters.
Notably, these clustered delta masses were detectable from almost all standard amino acids with a certain level of false positive occurrence ( Supplemental Table S4 ). However, those amino acids with previously reported delta masses were indeed found with high occurrence frequencies and matched with known PTMs and/or substitutions ( Supplemental Table 3 ). They were considered true positive ncAAs. For example, the cluster of 79.9669  0.0019 Da (n = 12,758, R 2 = 0.93) matched phosphorylation ( Fig. 2b, left panel) , which is reported at Ser, Thr, and Tyr and important for signal transduction (Hunter, 1995) . In human spermatozoa, two true positive ncAAs at Ser+79.9669 (73%) and Thr+79.9669 (18%) were identified ( Fig. 2b, right panel) . Similarly, delta masses clustered at 42.0111  0.0019 Da (n= 4950, R 2 = 0.91) matched acetylation ( Fig. 2c, left panel) , which is a modification of the epsilon-NH3 of Lys and alpha-NH3 of the N-terminal amino acid (Grunstein, 1997; Liu et al., 2008; Yi et al., 2011) . In human spermatozoa, at least three true positive ncAAs including Lys+42.0111 (25%), Met+42.0111 (53%), and Ala+42.0111 (7.5%) were identified ( Fig. 2c , right panel). Another cluster, 114.0438 Da (n = 1508, R 2 = 0.82), matched ubiquitylation ( Fig. 2d , left panel), which was detected with high frequency for all three true ncAAs including Lys+114.0438 (65%), Cys+114.0438 (19%) and Gly+114.0438 (10%; Fig. 2d , right panel).
Ubiquitylation at Lys and Cys has been previously reported (Bhoj and Chen, 2009; Hirsch et al., 2009; Sakamoto et al., 1999) , whereas Gly+114.0429 Da has not been reported previously. Finally, the cluster at -45.9872 (n = 736, R 2 = 0.74) matched Cys-Gly substitution, and was detected from one dominant true positive ncAA C-45.9872 (91%). In summary, from the 192 matched delta mass clusters, we identified 277 ncAAs, among which 137 were true possives that successfully matched with previously reported PTMs/substitutions (Supplemental Table 3 ) and 140 were unreported but occurred with high frequency and/or corresponded to chemically reactive modifications or substitutions.
To identify ncAAs for the 232 unmatched delta mass clusters, the ncAA results of the matched delta masses were used as a training dataset to build a decision tree model (Smith and Frank, 2016) . Additional criteria were as follows:
(1) each known cluster was typically reacted with not more than four amino acids; and (2) the total occurrence frequency of high-confidence ncAAs for each cluster was greater than 80%. The sensitivity and specificity of the model were 94.9% and 98.1%, respectively, for the matched delta masses. By applying this decision tree model to the unmatched delta mass clusters, we predicted 294 ncAAs with high sensitivity and specificity. Therefore, a total of 571 ncAAs were identified in human spermatozoa. Among them, 137 were previously kown PTMs and/or substitutions, and 434 were not previously reported ( Supplemental Table 5 ).
Numerous novel noncoded amino acids with undefined side-chain structures and unreported mechanisms
Remarkably, a large number of delta masses and ncAAs did not match previously known protein modifications and substitutions ( Fig. 3a) . These unreported delta masses were reasoned to form novel ncAAs with hitherto undefined side-chain structures and unreported mechanisms. However, many of the delta masses were highly selective and dependent on the chemical properties of the targeted amino acids, indicating putative modification mechanisms. For instance, some unreported delta masses occurred more frequently on basic residues, including delta mass 211.0968  0.0036 Da (n = 1895, R 2 = 0.62) on Lys (77%) and Arg (22%), and delta mass 353.2445  0.0028 Da (n = 948, R 2 = 0.58) on Lys (25%) and Arg (72%). Meanwhile, other unreported delta masses were selective for acidic residues, such as delta mass 52.9126  0.0028 Da (n = 3342, R 2 = 0.89) on Asp (23%) and Glu (22%). These results indicated a preference for reacting with the carboxyl group of acidic amino acids. In addition, the abundant delta mass cluster at 223.0347  0.0028 Da (n = 3569, R 2 = 0.91) was predominantly associated with the Cys residue (93%), indicating preferential reactivity with a thiol group. Thus, although the chemical structures were unknown, the selectivity of these ncAAs is indicative of their unique reactivity with the sidechains of the modified amino acids.
In summary, the most vulnerable amino acids for ncAAs in sperm proteins were Asn (n = 146,035, 25%), Cys (n = 116,520, 20%) and Lys (n = 113,032, 19%), which accounted for 65% of all delta masses ( Fig. 3b) . However, the most reactive amino acids for ncAA were Lys, Cys and Glu, which were targeted by 96, 70 and 49 different mutations/substitutions, respectively ( Fig. 3c ).
Widespread and polymorphous ncAA-containing protein sites For 571
ncAAs, a total of 29,053 non-redundant ncAA-containing protein sites were identified in human spermatozoa ( Supplemental Table 5 ). With a 26.75% protein coverage, the actual number of ncAA-containing protein sites was estimated to be up to 108,609, indicating the widespread existence of ncAA protein sites that might have a potentially crucial impact on protein structure and function. Interestingly, the proteins most often targeted by ncAAs were Akinase anchor protein 3/4 (AKAP3/4, n = 33,705), lactotransferrin (TRFL, n = 23,004), semenogelin-I/II (SEMG-I/II, n = 39,798), keratin type II cytoskeletal 1 (K2C1, n = 8378; Fig. 4a ). Some proteins were highly reactive to various different ncAAs, including SEMG-II, which was targeted by 646 ncAAs, AKAP4, which was targeted by 610 ncAAs, and TRFL, which was targeted by 538 ncAAs (Fig. 4b) . Taking SEMG-II as an example, 646 ncAAs spanned 267 amino acid positions, suggesting multiple ncAAs had to compete for limited amino acid positions. Among them, eight different ncAAs were found at Gln134 of SEMG-II ( Fig. 4c) , including Q+12.00045 (unknown, n = 32), Q-57.02116 (Gln>Ala substitution, n = 15), and Q+128.09574 (unknown, n = 12). Meanwhile, 47 different ncAAs were identified at SEMG-II Cys159, including C-33.9871 (dehydroalanine, n = 1091), C+72.02261 (unknown, n = 421), C+47.98546 (oxidised to cysteic acid, n = 370), and C+75.99925 (mercaptoethanol, n = 291).
To analyse the polymorphous nature of ncAAs, variations between healthy human subjects were analysed using ANOVA, and 351 ncAA-containing protein sites varied significantly between the healthy individuals (F >F0.01 (18,38) = 2.45, p <0.01, n>20; Supplemental Table 6 ). When clustered using Principal Component Analysis (Shen et al., 2015) , variations were largely the result of a significant increase in the occurrence of ncAAs in one or a few individuals ( Fig.   4d ), implying a polymorphous nature for ncAAs in healthy populations. The most abundant polymorphism was C-33.9871 (dehydroalanine, F = 3004), which was only detected at Cys12 of the tubulin beta-2C chain (TBB2C) in individual C27. Another example was E+17.04763 (unknown, F = 241), which was only detected at E322 of meiosis-specific nuclear structural protein 1 (MNS1) in individuals C44 and C31. In addition, D-15.9733 (unknown, F = 477) was only detected at D353 of annexin A11 (ANX11) in individual C44. These results suggest that polymorphous ncAA-containing protein sites contribute to population diversity and even human diseases.
Discrimination of patients with oligoasthenospermia by ncAAs
The clustered delta masses and ncAAs were compared between healthy humans and patients with oligo-asthenospermia, a male reproductive disease causing low sperm count and poor sperm motility. At the delta mass level, 62 of the identified clusters were up-or down-regulated > 2-fold in oligoasthenospermia patients ( Fig. 5a; Supplemental Table 7) . The most abundant down-regulated delta masses were 79.9668 (phosphorylation, -2.3-fold), 17.9567 (Leu/Ile>Met substitution, -3.67) and 211.0968 (unknown, -3.2-fold), whereas the mostly abundant up-regulated was 344.1659 (unknown, 18.0-fold) . At the ncAA level, 58 ncAAs (10%) were up-or down-regulated >2-fold ( Fig. 5b ; Supplemental   Table 8 ). Consistently, these included S+79.9668 (Ser phosphorylation, -2.3-fold), T+79.9668 (Thr-phosphorylation, -2.5-fold), K+211.09682 (unknown, -3.2-fold), K+42.0111 (acetylation, -6.4-fold) and E-14.0132 (E>D, +2.9-fold).
These results demonstrated that many delta masses and their ncAAs were dysregulated in oligoasthenospermia, most of which were not previously reported. These oligoasthenospermia-associated ncAAs presumably alter the side-chain structures and, ultimately, the overall protein function, thus contributing to pathogenesis.
To provide further support, ncAA-containing protein sites were clustered by Principal Component Analysis (Shen et al., 2015) , which clearly discriminated results into two distinct panels (Fig. 5c) Table 9 ). The most abundant and highly regulated protein sites are shown in Fig. 6a . Interestingly, SEMG and AKAP families were reciprocally regulated: all ncAA-containing sites of SEMGs were up-regulated in oligoasthenospermia ( Fig. 6b) , whereas most ncAA sites of AKAPs were down-regulated ( Fig. 6c) . A typical example was Ser-and Thrphosphorylation, which were exclusively down-regulated in AKAP4. Notably, most of the oligoasthenospermia-associated ncAA sites have not been previously reported. For example, the C-2.0147 modification at Cys908 of the coiled-coil domain-containing protein (Q96JN2) occurred 108 times in healthy people, but only twice in oligoasthenospermia patients ( Supplemental Table   9 ), suggesting a significant loss of disulfide bonds in the acrosome during spermatogenesis and fertilisation (Geng et al., 2016) . In conclusion, our results demonstrated that many ncAA protein sites were associated with oligoasthenospermia, implicating them in pathogenesis and suggesting they might be potential biomarkers for diagnosis and targeting.
Large numbers of amino acid substitutions irrelevant to SNPs Amino acid
substitutions among ncAAs were identified by matching the delta masses between the 20 standard amino acids ( Supplemental Table 10 ). Among 571 ncAAs, 98 matched with amino acid substitutions spanned 4882 different protein sites ( Fig. 7a ; Supplemental Table 11 ). Among these substitutions, N>D (2932 sites, n = 103,327) and Q>E (330 sites, n = 1804) were the most abundant substitution that share the same delta mass with hydrolytic deamination. The second most abundant class of substitutions occurred between side-chains with similar biochemical properties and reactivity. These included substitutions between Val and Leu/IIe hydrophobic side-chains (48 sites, n = 3647), between Glu and Asp negatively-charged carboxyl-containing side-chains (16 sites, n = 1326), and between Ser and Thr hydroxyl-containing side-chains (39 sites, n = 134). It should be emphasised that many highfrequency ncAA substitutions would require two spontaneous point mutations if they were generated at the genomic level. Examples include G>Q (82 sites, n = 363), A>V (24 sites, n = 117), V>T (6 sites, n = 120) and Q>A (10 sites, n = 157). As the frequency for spontaneous double point mutations was very low, this hints at the existence of as yet undefined mechanisms in addition to SNPs for these ncAA substitutions in humans.
To validate the identified ncAAs in human sperm, ncAA substitutions were determined by exon sequencing. Genomic DNA from three patients and three healthy people was prepared and exon sequences were determined. Missense SNPs were identified ( Supplemental Table 12 ) to compare with amino acid substitutions in human sperm ncAAs (Fig. 7b) . The results demonstrated that 40 out of 98 ncAA substitutions and 103 out of 4882 ncAA substitution protein sites were indeed matched with the missense SNPs ( Supplemental Table 13 ), and thus genomic mutations were confirmed as the cause in these cases.
However, most ncAA substitutions did not find corresponding SNPs, suggesting additional mechanisms operating at the level of post-transcription, RNA editing, and PTM were responsible for these ncAA substitutions.
In addition, the ncAA-substitution sites also differed between healthy individuals and oligoasthenospermia patients (Fig. 7c) . The most highly regulated substitutions included G>Q (-23-fold, n = 75), H>K (+20-fold, n = -136), and I>T (-13-fold, n = 63). The most highly up-regulated site occurred at G239V of carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6, +47-fold, n = 46), and the most highly down-regulated sites occurred at A1059V of EF-hand calcium-binding domain-containing protein 6 (EFCAB6, -70-fold, n = 38) and G98Q of sperm mitochondrial-associated cysteine-rich protein (SMCP, -23-fold, n = 75; Supplemental Table 13 ).
DISCUSSION
Herein, we developed a systematic workflow for identifying all possible protein residues not directly encoded by their genomic sequences, namely noncoded amino acids (ncAAs), in proteome. By measuring the delta masses between actual protein residues and coding amino acids, over a million nonzero delta masses were detected in human spermatozoa. These delta masses were grouped into 424 high-quality Gaussian clusters, and 571 mostly novel ncAAs spanning 29,053 protein sites were identified with confidence, suggesting a total of over 108,000 ncAA protein sites in humans. According to the definition, these ncAAs would cover the non-standard protein residues generated by point mutations and genomic editing (Drezen et al., 2016; Tak and Farnham, 2015) , RNA editing and transcriptional mutagenesis (Bregeon and Doetsch, 2011; Yang et al., 1995) , PTMs, and erroneous protein synthesis (Beltrao et al., 2012; Drummond and Wilke, 2009; Mathias et al., 2015) . Therefore, this proteomic approach identifies known and unknown PTMs, amino acid substitutions, missense SNPs, and all possible ncAAs with yet undefined mechanisms.
Strikingly, most of the delta masses and ncAAs corresponded to unresolved side-chain structures and were not previously reported. These novel ncAAs were chemically different from the standard amino acids and have different primary and presumably tertiary structures, ultimately affecting protein function.
By searching known delta mass databases, common PTMs were confidently identified and well covered, indicating the reliability of the approach. Wellknown PTMs such as phosphorylation, acetylation, methylation and ubiquitination were the most abundant of the identified ncAAs. The reliability of the unmatched delta mass clusters and novel ncAAs were strongly supported not only by their high frequencies and sharp peaks assigned by Goodness-of-Fitness of Gaussian regression with confidence, but also due to their high selectivity of occurrence over unique coding amino acids. Some of the unknown ncAAs occurred as frequently as acetylation and methylation, such as E/D+52.9126 (n = 3342, R 2 = 0.89), K+55.0069 (n = 412, R 2 = 0.73), and P+22.9676 (n = 1352, R 2 = 0.71), suggesting that their importance for protein structure and function. Interestingly, even for known delta masses, many of their ncAA-containing proteins and/or ncAA sites were not previously reported. The Importantly, ncAAs were demonstrated to discriminate human diseases.
Significant variations were observed between healthy individuals and patients
with oligoasthenospermia in terms of delta mass clusters, ncAAs and ncAAcontaining protein sites. Unlike SNPs, disease-associated ncAAs were considered relevant to specific biochemical reactions, and likely cause protein malfunctions, abnormal signal transduction, and pathogenic alteration in human diseases. Thus, the disease-associated ncAAs and ncAA-containing protein sites might be developed as diagnostic biomarkers and therapeutic targets.
By comparing with the standard amino acids, ncAAs in human spermatozoa were classified into amino acid substitutions and chemical modifications.
Approximately 13% of ncAAs were matched with amino acid substitutions, among which 40% were due to genomic mutations (SNPs), as confirmed by exon sequencing. It validated the efficiency of the ncAA approach that the ncAA substitutions corresponded with missense SNPs with consistence between the DNA and protein levels. Notably, 60% of ncAA substitutions did not match missense SNPs, leading to the hypothesis that most ncAA substitutions were generated by mechanisms additional to genomic point mutations, such as posttranscriptional RNA editing (Yang et al., 1995) , erroneous protein synthesis (Ribas de Pouplana, 2014) (Beltrao et al., 2012; Drummond and Wilke, 2009; Mathias et al., 2015) , and/or protein editing (Shen et al., 2015) .
In summary, widespread ncAAs were identified in human spermatozoa using a systematic approach, most of which were unreported PTMs and amino acid substitutions. These ncAAs were polymorphous and discriminative in healthy and diseased populations. This approach could be applied to different human tissues and organs to systematically identify disease-associated ncAAs that are potential biomarkers for diagnosis and drug targeting. The method opens up a new dimension for understanding protein structure, function, and regulation relevant to physiological and pathological mechanisms. Note that oxidation was omitted from the calculation. c, Gaussian regression of phosphorylation clustered at delta mass 79.9669 Da (red curve, n = 12758, R 2 = 0.93), 73% of which were found at Ser and 8% at Thr. However, Tyr phosphorylation only accounted for ~1%. d, Gaussian regression of acetylation clustered at delta mass 42.0111 Da (red curve, n = 4950, R 2 = 0.91), with 53% found at Met, 25% at Lys and 7% at Ala. e, Gaussian regression of ubiquitylation clustered at delta mass 114.0438 Da (red curve, n = 1508, R 2 = 0.82), with 65% found at Lys, 19% at Cys and 7% at Gly. Table S11a ). The top 35 most abundant ncAA substitutions (n > 100) are shown. b, Validation of ncAA substitutions by exon sequencing ( Supplemental Table S13 ). Missense SNPs in three healthy individuals and three oligoasthenospermia patients were determined by exon sequencing and Table S11b ). The most up-/downregulated ncAA substitutions (p<0.05, t-test) are shown.
Figure legends
EXPERIMENTAL PROCEDURES
Sample preparation Human sperm samples were collected from 24 healthy people and 24 patients with asthenospermia under the protocol approved by the Institutional Review Board of Reproductive Medicine, Shandong University.
Written consent was obtained from all participants. Sperm samples were washed separately three times with ice-cold PBS (0.1 M Na2HPO4, 0.15 M NaCl, pH 7.5), and re-suspended in 1 ml of chilled 1 RIPA lysis buffer (Millipore 20-188, USA) supplemented with 10 μl of 500 mM DTT and 10 μl of protease inhibitor cocktail (Roche, Switzerland) to protect against oxidation and degradation. After sonication three times for 5 s on ice, lysates were centrifuged at 13,000g for 20 min at 4C. Supernatants were collected and protein concentrations determined using the Bicinchoninic Acid (BCA) assay (Beyond, China). Wide-tolerance searching MS/MS spectra were searched against the human protein database with wide MS tolerance using MASCOT (Perkins et al., 1999) , SEQUEST (Yates, 2015) , MODa (Na and Paek, 2015) and Byonic (Bern et al., 2012) . For wide-tolerance searches with SEQUEST HT in Proteome Discover 2.0 (ThermoFisher), the precursor ion tolerance (peptide) was set to 500 Da, the fragment ion tolerance (fragment) was 0.6 Da, two missed cleavages by trypsin were allowed, the false discovery rate (FDR) for peptides was 1%, and the threshold for accepted MS/MS spectra was set at high confidence. For wide-tolerance searching with MODa v1.21, peptide tolerance was set to 1 Da, the fragment tolerance was 0.6 Da, BlindMode was 1, the modification was set from -200 to 1000 Da, two missed cleavages by trypsin were allowed, the FDR for peptides was 1%, the threshold score and the probability of the peptides and spectrum match were 30 and 0.95, respectively. For wildcard searching with Byonic v2.6, MS/MS spectra were first searched normally using Byonic v2.6 to create a focused human protein dataset. Wildcard searching was then performed against the focused protein dataset. The precursor ion tolerance was set to 10 ppm, and the fragment ion tolerance was 0.6 Da. Trypsin (full specific cleavage) was specified as the cleavage enzyme and up to two missed cleavages were allowed. The modification masses of wildcard searches were set from -200 to 1000 Da.
Pre-separation and trypsin digestion
Nonzero delta mass clustering Typically, MS/MS spectra were searched against the human protein database using the wildcard search in Byonic software (Bern et al., 2012) and filtered with Score 300, DeltaModsScore 10, FDR2D 0.01 and FDR_uniq.2D 0.01. All amino acid residues that were different from coding genomic sequences were identified to calculate nonzero delta masses (delta mass >0.01), the mass differences between the actual and theoretical (coding) amino acids. These nonzero delta masses were assigned noncoded amino acids (ncAAs). For occurrence analysis, delta masses were rounded to four decimal places and the number of redundancies was considered as the frequency of the delta mass. For clustering, delta masses were divided into subgroups with 1 Da intervals bounded by n-0.5 and n+0.5 Da (n = -200 to 1000). Delta masses in each mass window were analysed by multivariate clustering using Gaussian mixture components (Fraley et al., 2012) with the following constraints: (1) peak half-width >1 ppm; (2) peak distance >2 peak widths; (3) cluster size >20. Clusters within each window were determined by the Bayesian Information Criterion (BIC) (Fraley and Raftery, 1998) , where larger BIC values indicate a stronger model and confidence in the number of clusters. Next, clusters in each window were fitted individually with Gaussian regression to calculate the peak value (expected delta mass), the SD, and the Goodness-of-Fit (R 2 ). Delta mass clusters were categorised by matching with previously known PTMs, and amino acid substitutions in UniMod, RESID, ExPASy, and ABRF databases. Matched clusters were considered as the true delta masses in the examined protein samples. Unmatched clusters were assigned with confidence only when the Goodness-of-Fit R 2 >0.2 and/or the cluster was predominantly associated at a single amino acid (>50% Table S14 ). Based on this classification, a score s was assigned for every amino acid i (I = 1…20) in each delta mass cluster j (I = 1…192). Thus, the score s i,j was computed as follows:
where class-score i,j is the score transformed from H/M/L classification of amino acid i in cluster j (class-score i,j = 2 for class H, 0.5 for M, 0 for L), frequency i,j is the occurrence frequency of amino acid i in cluster j,
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